Medasense is the developer of a unique technology that objectively monitors and quantifies the patient’s pain response level using artificial intelligence algorithms and a proprietary noninvasive sensor platform.
OTV saw the potential in Medasense before we had commercialized our product and before we had outcome studies showing that our product not only works but also helps to make a difference for patients. They helped to cross the financial chasm from an R&D company to a commercial company, while crystalizing our mindset on the importance of creating value while being very cautious with available resources.